These associations were highly significant regardless of which sRAGE platform was used, whether plasma or serum was assayed, or how emphysema was measured (quantitative or visual).
← all excerpts
Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
1
—
—